Predictive Modeling of Tacrolimus Dose Requirement Based on High-Throughput Genetic Screening-Reference-Cited by-同舟云学术

Predictive Modeling of Tacrolimus Dose Requirement Based on High-Throughput Genetic Screening

Published:2016-10-07 Issue:4 Volume:17 Page:1008-1019
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Damon C.¹,Luck M.¹²,Toullec L.³,Etienne I.⁴,Buchler M.⁵,Hurault de Ligny B.⁶,Choukroun G.⁷,Thierry A.⁸,Vigneau C.⁹,Moulin B.¹⁰,Heng A.-E.¹¹,Subra J.-F.¹²,Legendre C.¹³,Monnot A.¹,Yartseva A.¹,Bateson M.¹,Laurent-Puig P.²³¹⁴,Anglicheau D.¹³,Beaune P.²³¹⁴,Loriot M. A.²³¹⁴,Thervet E.²¹⁵,Pallet N.²³¹⁴¹⁵

Affiliation:

1. Hypercube Institute; Paris France

2. Paris Descartes University; Paris France

3. Department of Clinical Chemistry; Georges Pompidou European Hospital; Assistance Publique Hôpitaux de Paris; Paris France

4. Department of Nephrology; Rouen University Hospital; Rouen France

5. Department of Nephrology; Tours University Hospital; Tours France

6. Department of Nephrology; Caen University Hospital; Caen France

7. Department of Nephrology; Amiens University Hospital; Amiens France

8. Department of Nephrology; Poitiers University Hospital; Poitiers France

9. Department of Nephrology; Rennes University Hospital; Rennes France

10. Department of Nephrology; Strasbourg University Hospital; Strasbourg France

11. Department of Nephrology; Clermont-Ferrand University Hospital; Clermont-Ferrand France

12. Department of Nephrology; Angers University Hospital; Angers France

13. Department of Nephrology; Necker Hospital; Assistance Publique Hôpitaux de Paris; Paris France

14. Institut National pour la Santé et la Recherche Médicale (INSERM) U1147; Paris France

15. Department of Nephrology; Georges Pompidou European Hospital; Assistance Publique Hôpitaux de Paris; Paris France

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajt.14040/fullpdf

Reference29 articles.

1. The role of pharmacogenomic biomarkers in predicting and improving drug response: Part 2: Challenges impeding clinical implementation;Ventola;P T,2014

2. Role of pharmacogenomic biomarkers in predicting and improving drug response: Part 1: The clinical significance of pharmacogenetic variants;Ventola;P T,2013

3. Pharmacogenetics in the evaluation of new drugs: A multiregional regulatory perspective;Maliepaard;Nat Rev Drug Discov,2013

4. Opportunities to optimize tacrolimus therapy in solid organ transplantation: Report of the European consensus conference;Wallemacq;Ther Drug Monit,2009

5. A new functional CYP3A4 intron 6 polymorphism significantly affects tacrolimus pharmacokinetics in kidney transplant recipients;Elens;Clin Chem,2011

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tacrolimus—why pharmacokinetics matter in the clinic;Frontiers in Transplantation;2023-08-21

2. Drug transporters are implicated in the diffusion of tacrolimus into the T lymphocyte in kidney and liver transplant recipients: Genetic, mRNA, protein expression, and functionality;Drug Metabolism and Pharmacokinetics;2022-12

3. Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and Pharmacodynamics;Pharmaceutics;2022-08-23

4. Influencia del polimorfismo de CYP3A4 y CYP3A5 en la farmacocinética de tacrolimus en receptores de trasplante renal. Revisión narrativa;Ciencia, Tecnología y Salud;2021-12-12

5. The influence of recipient SLCO1B1 rs2291075 polymorphism on tacrolimus dose–corrected trough concentration in the early period after liver transplantation;European Journal of Clinical Pharmacology;2021-01-02